Bridgeway Capital Management, LLC Simulations Plus, Inc. Transaction History

Bridgeway Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$49.67 - $68.96 $178,812 - $248,255	-3,600 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$57.51 - $75.36 $149,526 - $195,936	-2,600 Reduced 41.94%	3,600 $271,000
Q2 2020 Aug 14, 2020	SELL	$32.91 - $59.82 $174,422 - $317,046	-5,300 Reduced 46.09%	6,200 $371,000
Q1 2020 May 15, 2020	BUY	$26.79 - $38.99 $83,049 - $120,869	3,100 Added 36.9%	11,500 $402,000
Q4 2019 Feb 14, 2020	BUY	$29.07 - $35.63 $244,188 - $299,292	8,400 New	8,400 $244,000

180

15.9M

3.9K

200

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $631M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.